Surmodics, Inc.
NASDAQ:SRDX
39 (USD) • At close January 8, 2025
Overzicht | Financiële gegevens
Bedrijfsnaam | Surmodics, Inc. |
Symbool | SRDX |
Munteenheid | USD |
Prijs | 39 |
Beurswaarde | 557,469,900 |
Dividendpercentage | 0% |
52-weken bereik | 25.17 - 42.44 |
Industrie | Medical Devices |
Sector | Healthcare |
CEO | Mr. Gary R. Maharaj |
Website | https://www.surmodics.com |
An error occurred while fetching data.
Over Surmodics, Inc.
Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment engages in the
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)